Revenue - Revenue Recognition (Details) - Revenue Benchmark	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Customer Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of net sales	100.00%	100.00%	100.00%	100.00%
Product Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of net sales	100.00%	100.00%	100.00%	100.00%
Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of net sales	100.00%	100.00%	100.00%	100.00%
Americas | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of net sales	49.00%	48.00%	49.00%	48.00%
Europe, Middle East, Africa | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of net sales	42.00%	44.00%	43.00%	44.00%
Asia Pacific | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of net sales	9.00%	8.00%	8.00%	8.00%
High-Value Components | Product Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of net sales	47.00%	42.00%	45.00%	43.00%
Standard Packaging | Product Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of net sales	25.00%	28.00%	26.00%	29.00%
Delivery Devices | Product Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of net sales	5.00%	6.00%	5.00%	4.00%
Contract-Manufactured Products | Product Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of net sales	23.00%	24.00%	24.00%	24.00%
Biologics | Customer Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of net sales	32.00%	26.00%	29.00%	25.00%
Generics | Customer Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of net sales	18.00%	20.00%	19.00%	20.00%
Pharma | Customer Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of net sales	27.00%	30.00%	28.00%	31.00%
Contract-Manufactured Products | Customer Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of net sales	23.00%	24.00%	24.00%	24.00%